Sudden onset of haemoptysis and hypoxia after recombinant human thyroid-stimulating hormone use in a patient with papillary thyroid carcinoma and pulmonary metastases.

Vethakkan SR; Roberts V; Ward GM

首页> 外文期刊>Internal medicine journal >Sudden onset of haemoptysis and hypoxia after recombinant human thyroid-stimulating hormone use in a patient with papillary thyroid carcinoma and pulmonary metastases.

【24h】

Sudden onset of haemoptysis and hypoxia after recombinant human thyroid-stimulating hormone use in a patient with papillary thyroid carcinoma and pulmonary metastases.

机译：患有甲状腺乳头状癌和肺转移的患者使用重组人甲状腺刺激激素后突然出现咯血和缺氧。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Recombinant human thyroid-stimulating hormone (rhTSH) is an equivalent1 and sometimes superior alternative to thyroid hormone withdrawal (THW) in the management of differentiated thyroid carcinoma. We report a case of haemoptysis and hypoxia after Thyrogen (rhTSH) administration (before radio-ablation).

机译：在分化型甲状腺癌的治疗中，重组人促甲状腺激素（rhTSH）是替代甲状腺激素（THW）的等效方法，有时甚至是更好的选择。我们报告了甲状腺素（rhTSH）给药后（放疗前）的一次咯血和低氧。

著录项

来源
《Internal medicine journal》 |2009年第12期|共2页
作者
Vethakkan SR; Roberts V; Ward GM;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Sudden onset of haemoptysis and hypoxia after recombinant human thyroid-stimulating hormone use in a patient with papillary thyroid carcinoma and pulmonary metastases. [J] . Vethakkan SR, Roberts V, Ward GM Internal medicine journal . 2009,第12期

机译：患有甲状腺乳头状癌和肺转移的患者使用重组人甲状腺刺激激素后突然出现咯血和缺氧。
2. Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone. [J] . David A, Blotta A, Bondanelli M, The Journal of Nuclear Medicine . 2001,第10期

机译：重组人促甲状腺激素给药后，分化型甲状腺癌患者的血清甲状腺球蛋白浓度和（131）I全身扫描结果。
3. Serum Thyroglobulin Concentrations and 131I Whole-Body Scan Results in Patients with Differentiated Thyroid Carcinoma After Administration of Recombinant Human Thyroid-Stimulating Hormone [J] . Alessia David, Annabella Blotta, Marta Bondanelli, The Journal of Nuclear Medicine . 2001,第10期

机译：重组人促甲状腺激素给药后分化型甲状腺癌患者的血清甲状腺球蛋白浓度和131I全身扫描结果
4. Characterization of a novel rearrangement from theret/PTC family in a case of radiation-associatedhuman thyroid papillary carcinoma [C] . Vladimir A. Saenko, Tatiana I. Rogounovitch, Yuki Shimizu-Yoshida International Consortium for Medical Care of Hibakusha and Radiation Life Science . 2003

机译：在辐射相关的甲状腺乳头状癌的情况下，表征来自特权/ PTC家族的新型重排
5. Recombinant Human Thyroid-Stimulating Hormone-Aided Remnant Ablation Achieves a Response to Treatment Comparable to That with Thyroid Hormone Withdrawal in Patients with Clinically Relevant Lymph Node Metastases [O] . Fabián Pitoia, Erika Abelleira, Graciela Cross 2014

机译：重组人促甲状腺激素辅助残余消融治疗对临床相关淋巴结转移患者的治疗与甲状腺激素戒断相当
6. Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node metastases not limited to the central compartment (cN1b) [O] . Pedro Weslley Rosario, Gabriela Franco Mourão, Maria Regina Calsolari 2017

机译：重组人TSH与甲状腺激素戒断在助剂治疗中，乳头状甲状腺癌患者的放射性碘和临床表观淋巴结转移不限于中央隔室（CN1B）

Sudden onset of haemoptysis and hypoxia after recombinant human thyroid-stimulating hormone use in a patient with papillary thyroid carcinoma and pulmonary metastases.

摘要

著录项

相似文献

相关主题

期刊订阅